| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 48 |
| 1 | BEVACIZUMAB | 32 |
| 2 | PACLITAXEL | 28 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 26 |
| 4 | CISPLATIN | 25 |
| 5 | NIVOLUMAB | 19 |
| 6 | DOCETAXEL | 15 |
| 7 | DOCETAXEL ANHYDROUS | 15 |
| 8 | PEMETREXED DISODIUM | 14 |
| 9 | DURVALUMAB | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PORFIMER SODIUM | 4 | 0.0117 |
| 1 | MEBENDAZOLE | 1 | 0.0013 |
| 2 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| 3 | ERLOTINIB HYDROCHLORIDE | 10 | 0.0008 |
| 4 | ETHIODIZED OIL | 1 | 0.0008 |
| 5 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 6 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 7 | NALDEMEDINE | 1 | 0.0006 |
| 8 | DROPERIDOL | 1 | 0.0006 |
| 9 | SATRALIZUMAB | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 11 | 0.0005 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 35 | 0.0004 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 5 | Platinum-based Drug [EPC] | 76 | 0.0003 |
| 6 | Microtubule Inhibitor [EPC] | 43 | 0.0003 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 32 | 0.0002 |
| 8 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |